Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Oved Amitay, Akshay Vaishnaw, Jared Gollob, Lubomir Nechev

Premium

Alnylam Pharmaceuticals has made a number of changes to its senior management team, hiring Oved Amitay to fill the newly created position of vice president and head of commercial.

Amitay previously served as vice president of strategic development for the personalized genetic health business unit of Genzyme.

The company has also promoted senior vice president and CMO Akshay Vaishnaw to executive vice president and CMO; senior director Jared Gollob to vice president of clinical research; and senior director Lubomir Nechev to vice president of process service.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.